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Abstract. The distribution of norovirus (NoV) genogroup II in children < 5 years of age admitted to a south Indian
hospital with diarrhea was investigated. Viral RNA extracted from 282 stool samples were screened for NoV GII and
positive amplicons sequenced. Twenty-eight (9.9%) had NoV GII infection with a median age of 6 months, with more
severe episodes of diarrhea among infected (median Vesikari score 13, interquartile range [IQR] 10–15) than children
without infection (median score 10, IQR 8–13, P = 0.002). The study documents NoV GII infections as an important
cause of gastroenteritis and the genetic diversity of circulating strains.
INTRODUCTION
Noroviruses (NoVs) are the most important cause of non-
bacterial gastroenteritis in all ages in both developed and
developing countries.1 It has recently been estimated that
each year NoVs cause 64,000 episodes of diarrhea requiring
hospitalization and 900,000 clinic visits among children in
industrialized countries and up to 1.1 million hospitalizations
and 200,000 deaths of children < 5 years of age in developing
countries.2,3 NoVs cause outbreaks of acute gastroenteritis in
a variety of settings, such as schools, restaurants, hospitals, cruise
ships, nursing homes, and military settings.4 Norovirus infections
accounted for 18.2% of outbreaks and 65% of closures of
hospital wards during 2008 and 2009 in the United States.5
A recent review of reports from both developed and devel-
oping countries indicates that the prevalence rates of NoV
gastroenteritis in hospitalized children range from 6% to
48%, with an overall prevalence of 14%.6 There have been
recent reports of NoV outbreaks in neonatal nurseries associ-
ated with clinical presentations such as necrotizing enteroco-
litis, diarrhea, vomiting, abdominal distension, and fever.7–9
The primary objective of this study was to identify the preva-
lence of NoV GII among children < 5 years of age admitted to
the hospital with diarrhea.
MATERIALS ANDMETHODS
Study population. The study was carried out at the Christian
Medical College (CMC), a 2,695-bed tertiary care hospital in
Vellore, southern India with 60 neonatal and 84 pediatric beds.
There are ~400 pediatric admissions every month. This
includes about 40 cases presenting with diarrhea requiring
hospitalization for rehydration. Stool samples were collected
from children < 5 years of age who were admitted to the
pediatric ward with acute gastroenteritis between the years
2005 and 2006 and screened for NoV GII. All stool samples
collected were transported within 2 hours to the laboratory
and stored at −70°C until testing. Diarrheal stool samples
were screened for parasite ova and cysts by microscopy
and for rotavirus by enzyme-linked immunosorbent assay
(Rota IDEIA; Dako, Ely, UK).
Written informed consent was obtained from parents of
all children before enrollment, and the study was approved
by the Institutional Review Board of the Christian Medical
College, Vellore.
Viral RNA extraction and complementary DNA synthesis.
Viral RNA was extracted from 200 mL of 20% fecal suspension
in minimal essential medium (MEM) using the guanidium
isothiocyanate-silica method.10 A known positive control was
included in all extractions, to detect polymerase chain reac-
tion (PCR) inhibition. The RNA eluted was converted to
complementary DNA (cDNA) by reverse transcription at
37°C for an hour, with random hexamers (Pd[N]6, Pharmacia
Biotech, Little Chalfont, Buckinghamshire, UK). The cDNA
were stored at −20°C until further use.
Detection and characterization of NoV GII strains. The
cDNA was used as a template for the amplification of the
ORF 1–2 regions using primers GIIFB1, GIIFB2, GIIFB3/
GIISKR to amplify a 468 bp fragment of the ORF 1–2 region.11
The PCR amplicons were resolved by gel electrophoresis using
1.5%Agarose gel (Medox, Chennai, India) containing ethidium
bromide (0.5 mg/mL) in 1X TBE (Tris–Base Boric acid–
EDTA, Sigma-Aldrich, St. Louis, MO) buffer. Sequencing of
the positive amplicons was carried out by using the ABI
PRISM Big Dye Terminator cycle sequencing ready reaction
kit (Applied Biosystems, Carlsbad, CA). Sequences were
resolved using an automated DNA sequencer ABI PRISM
310 Genetic Analyzer. Nucleotide sequence similarity searches
were performed using the National Center for Biotechnol-
ogy Information basic local alignment search tool (BLAST)
server (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). Multiple
sequence alignment was then carried out with ClustalW align-
ment algorithm of the BioEdit Sequence Editor v7.0.9.0
(http://www.mbio.ncsu.edu/bioedit/bioedit.html) by including
reference sequences obtained from GenBank. Neighbor-
joining method (10,000 pseudo replicates) with MEGA soft-
ware (version 4, http://www.megasoftware.net/) was used to
assign the samples to a genogroup if the polymerase and/or
capsid region shared > 70% homology at the nucleotide (nt)
level to those of strains within a recognized genogroup. Geno-
types were assigned based on > 90% homology at the nt level
with other strains within a given genotype.12
Statistical analysis. The data were analyzed using STATA
10.0 for Windows (STATA Corp., College Station, TX).
Descriptive analysis was performed for all explanatory vari-
ables. Statistical significance of the observed differences in
outcome between explanatory variables was assessed using
the c2 test or Fisher’s exact test for categorical variables and
two-tailed t test or Mann-Whitney U test for continuous vari-
ables, depending on the distribution of the data.
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A total of 282 children < 5 years of age admitted to the
hospital between the years 2005 and 2006 with gastrointestinal
symptoms were screened for norovirus GII. Clinical informa-
tion was collected for all children. The median interquartile
range (IQR) age of children with diarrhea was 9 (4–16) months.
The median interquartile range (IQR) Vesikari score of diar-
rheal severity was 10 (8–13) and the children required admis-
sion for a mean (SD) duration of 3 (±2) days.
Of the 282 children, 28 (9.9%) had NoV GII infection.
Sixteen (57.1%) of these 28 children were males. Of the
254 children without NoV infection 182 (71.7%) were males,
although this difference was not statistically significant
(P = 0.456). The median (IQR) age of NoV diarrhea was
8.5 (7–12) months, whereas for those who did not have
NoV diarrhea it was 9 (4–17) months, which was comparable
(P = 0.676).
When the severity of diarrheal episodes were compared
between those with and without NoV infection, the episodes
of diarrhea associated with NoV infection were found to be
more severe (median Vesikari [IQR] = 13 [10–15]) than
those not associated with NoV infection (median Vesikari
[IQR] = 10 [8–13], P = 0.002). When the associated clinical
symptoms were individually compared between children with
and without NoV diarrhea, a significantly higher proportion
of children with NoV diarrhea had associated vomiting than
other children (P = 0.044) (Table 1). Other symptoms such as
fever and degree of dehydration were comparable between
the two groups (Table 1). Of the 282 children, 30 (10.6%)
were positive for rotavirus, but none of the NoV positive
children had a co-infection with rotavirus. No parasitic path-
ogens were identified. No significant difference was observed
in the clinical features between the rotavirus and norovirus
infected children.
The sequencing of the amplified products from the positive
samples showed a predominance of NoV GII.4 accounting for
42.9% (12 of 28) followed by GII.3, GII.2, and GII.1 (25%,
17.9%, and 14.3%, respectively) (Figures 1 and 2). A compar-
ison of age, sex, and other clinical symptoms including need
for rehydration of children with NoV GII.4 versus other
NoV genotypes showed no significant difference. Nucleotide
sequences of positive samples from the study have been
deposited in the GenBank and the accession numbers are
KC594868–KC594888.
DISCUSSION
This study documents the proportion of NoV GII infections
and genetic diversity of circulating NoV strains among Indian
children < 5 years of age admitted with diarrhea. The rate of
9.9% is similar to studies reported from other high- and low-
income countries.13–17
Previous reports have shown that NoV GII strains are more
likely to induce vomiting and severe diarrhea among children;
similar observations were made in the current study.18,19
A recent review that examined NoV outbreaks across the
world showed an increase in NoV diarrhea.20 This could be
caused by the rapidity by which NoV has evolved that leads to
distinct strains emerging every 2–4 years or wider availability
of diagnostic tools.
Hospital-based studies from India between 2003 and 2009
reported a 6% prevalence of NoV associated diarrhea among
children £ 5 years of age,21–24 which is lower than the current
study. This variation could be a result of the detection method
used. A recent comparison of different primer sets for the
detection of NoV GII showed that a higher detection can be
obtained by either using multiple primer sets or using a sensi-
tive nested reverse transcription-polymerase chain reaction
assay.25 Nucleotide sequence analysis of the positive samples
showed a predominance of NoV GII.4 (43%) followed by
GII.3, GII.2, and GII.1.
A previously published study from the same area showed
the prevalence of NoV and sapovirus (SaV), in the community
and hospital settings,23 with predominance of GII, but at a
lower level than currently reported. A reason for this increase
could be the circulation or evolution of newer strains caused
by sequence mutation and/or recombination, a possibility that
needs further exploration.
The higher severity of NoV-associated diarrhea and the
predominance of the NoV GII strains in hospital and commu-
nity settings have heightened the need for routine stool test-
ing to identify the etiology of gastroenteritis, particularly to
prevent inappropriate antibiotic usage and inform the need
for future vaccines. In India, NoVs are not covered in the
routine stool testing in most laboratories and hence the viral
distribution patterns across the country are not known. The
current study shows the NoV GII are an important cause of
diarrhea and that GII.4 are the most common.
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Table 1
Comparison of clinical symptoms and treatment needs of children





N = 254 P value
Presence of vomiting 22 (78.6%) 150 (59.1%) 0.044
Fever (> 37 °C) 14 (50%) 129 (50.8%) 0.937
Dehydration 24 (85.7%) 174 (68.5%) 0.059
Intravenous fluid replacement 27 (96.4%) 237 (93.3%) 1.000
Figure 1. Distribution of norovirus genotypes among 28 children
hospitalized with noroviral gastroenteritis in Vellore.
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Figure 2. Dendrogram constructed using neighbor-joining of nucleotide sequences corresponding to a fragment of 468 bp of the ORF 1-2 region
of the NoV capsid encoding gene. Bootstrap P values for 10,000 pseudoreplicates are shown.
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